Compliance of National Cancer Institute-Designated Cancer Centers With January 2021 Price Transparency Requirements.

Childers, Christopher P; Guorgui, Jacob; Siddiqui, Sami; Donahue, Timothy

Childers, Christopher P; Guorgui, Jacob; Siddiqui, Sami; Donahue, Timothy.

Afiliação

Childers CP; Department of Surgery, David Geffen School of Medicine at UCLA, Ronald Reagan UCLA Medical Center, Los Angeles, California.
Guorgui J; David Geffen School of Medicine at UCLA, Los Angeles, California.
Siddiqui S; Department of Molecular, Cell, and Developmental Biology at UCLA, Los Angeles, California.
Donahue T; Department of Surgery, David Geffen School of Medicine at UCLA, Ronald Reagan UCLA Medical Center, Los Angeles, California.

JAMA Surg ; 157(10): 959-960, 2022 10 01.

Article em En | MEDLINE | ID: mdl-35947377

This cross-sectional study investigates the compliance rate of hospitals with National Cancer Institutedesignated cancer center status with the Centers for Medicare & Medicaid Services January 2021 price transparency requirements.

Assuntos

Medicare; Neoplasias; Humanos; Medicaid; National Cancer Institute (U.S.); Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Medicare / Neoplasias Tipo de estudo: Health_economic_evaluation / Observational_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: JAMA Surg Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google